Sano, Yuji http://orcid.org/0000-0003-3714-4983
Azuma, Yumiko
Tsunenari, Toshiaki
Kayukawa, Yoko
Shinozuka, Junko
Fujii, Etsuko
Amano, Jun
Nishito, Yukari
Maruyama, Toru
Kinoshita, Yasuko
Sakamoto, Yuichiro
Yoshida, Ayae
Miyazaki, Yoko
Sato, Yuta
Teramoto-Seida, Chifumi
Ishiguro, Takahiro
Tanaka, Takayoshi
Kitazawa, Takehisa
Endo, Mika
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd | Chugai Pharmaceutical
Article History
Received: 17 March 2021
Accepted: 25 August 2022
First Online: 7 September 2022
Competing interests
: All authors are employees of Chugai Pharmaceutical Co., Ltd, which is involved in the research and development of medicines. This study was funded by Chugai Pharmaceutical Co., Ltd. The patent application (WO2017159287: Cell injury inducing therapeutic drug for use in cancer therapy) related to these findings was published by Y.A., Y. Kinoshita., T.T., T.I., M.E. and Y. Sano.